跳至主要内容
临床试验/IRCT201702231165N18
IRCT201702231165N18已完成1 期

Evaluation of efficacy and safety of topical naloxone in control of chronic pruritus in patients with neurodermatitis

Baqiyatallah University of medical sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70 years 至 30 years(—)
性别
All

入选标准

  • The patient has no addiction; have not been treated with any form of topical steroids; diagnosis of neurodermitis has been confirmed by a physician; the content form should have been completed by the patient; age between 25 and 65 years; have no other skin disorders; accessible at all times during the trial; do not leave the treatment after one week; do not have allergy to the medication. Exclusion criteria: when disease become uncontrollable; severe reaction or allergy to the medication; patients’ age less the 25 and more than 65 years

排除标准

  • 未提供

研究者

发起方
Baqiyatallah University of medical sciences

相似试验